vitiligo
Conditions
Interventions
test group:308nm excimer laser + compound betamethasone injection
control group:Tacrolimus ointment + compound times betamethasone injection
Sponsors
The First Hospital of China Medical University
Eligibility
Sex/Gender
All
Age
14 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) age 10-70 years old, inpatient or outpatient, male or female; (2) meet the diagnostic criteria of clinically diagnosed with primary advanced (advanced standards, see Annex 2) patients with vitiligo of the face and neck; (3) subjects volunteered to participate, be required to sign an informed consent form; (4) leukoplakia spread in the neck of the double-side, with at least one lesions greater than 1cm in diameter.
Exclusion criteria
Exclusion criteria: (1) pregnant and lactating women; (2) serious heart, liver, renal insufficiency; (3) pre-cancerous skin lesions; (4), systemic lupus erythematosus (SLE), dermatomyositis ultraviolet treatment contraindications; (5) with immunosuppressive therapy; Nearly 2 months (6) received corticosteroids, calcineurin inhibitors, NB-UVB excimer laser treatment, any treatment received nearly January, at the same time to participate in clinical trials; (7) can not adhere to treatment; (8) tacrolimus sensitive; (9) secondary vitiligo (secondary to discoid lupus erythematosus, chronic eczema, vitiligo).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lesions change; | — |
Countries
China
Contacts
Public ContactXing-hua Gao
Outcome results
None listed